SNMMI and the Alzheimer's Association have developed draft appropriate use criteria for beta-amyloid imaging that are available for comment through Dec. 6. View and comment.
Published in Brief:
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||